2023
Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy.
Harkenrider M, Fields E, Chopra S, Damast S, Kidd E, Chino J. Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy. International Journal Of Radiation Oncology • Biology • Physics 2023, 115: 269-275. PMID: 36621226, DOI: 10.1016/j.ijrobp.2022.07.1833.Peer-Reviewed Original Research
2021
Does Prophylactic Paraortic Lymph Node Irradiation Improve Outcomes in Women With Stage IIIC1 Endometrial Carcinoma?
Yoon J, Fitzgerald H, Wang Y, Wang Q, Vergalasova I, Elshaikh MA, Dimitrova I, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino J, Natesan D, Russo AL, Lea JS, Albuquerque KV, Lee LJ, Hathout L. Does Prophylactic Paraortic Lymph Node Irradiation Improve Outcomes in Women With Stage IIIC1 Endometrial Carcinoma? Practical Radiation Oncology 2021, 12: e123-e134. PMID: 34822999, DOI: 10.1016/j.prro.2021.10.002.Peer-Reviewed Original ResearchConceptsStage IIIC1 endometrial cancerPelvic radiation therapyOverall survivalEndometrial cancerRadiation therapySurvival outcomesFirst recurrenceHazard ratioRFS ratesCommon siteRecurrence-free survival ratesMulti-institutional retrospective studyPropensity scoreCox proportional hazards modelImproved survival outcomesKaplan-Meier methodProportional hazards modelInternational FederationNew therapeutic approachesAdjuvant chemotherapyDistant recurrenceSystemic chemotherapyImprove OutcomesClinical outcomesDistant metastasis
2019
Literature Review of Vaginal Stenosis and Dilator Use in Radiation Oncology
Damast S, Jeffery DD, Son CH, Hasan Y, Carter J, Lindau ST, Jhingran A. Literature Review of Vaginal Stenosis and Dilator Use in Radiation Oncology. Practical Radiation Oncology 2019, 9: 479-491. PMID: 31302301, PMCID: PMC7944435, DOI: 10.1016/j.prro.2019.07.001.Peer-Reviewed Original ResearchConceptsVaginal dilator therapyVaginal stenosisPelvic radiation therapyRisk factorsRadiation therapyOutcomes of patientsRadiation-induced vaginal stenosisRadiation oncologyStrong risk factorCare of womenDilator therapyDilator useRT doseProspective dataSexual functionVaginal dilatorsVaginal changesOptimal durationRadiation oncologistsEarly manifestationStenosisLiterature reviewSearch termsProspective effortsPathophysiology